Home
Mail
Search
News
Finance
Sport
TV
Lifestyle
Entertainment
Mobile
Horoscopes
More
Yahoo
Mail
Watchlists
My Portfolios
Market Data
Latest News
Industries
Personal Finance
Currency Convertor
Video
New Zealand markets open in 9 hours 42 minutes
NZX 50
11,805.09
-141.34
(-1.18%)
NZD/USD
0.5941
-0.0008
(-0.14%)
NZD/EUR
0.5549
+0.0009
(+0.16%)
ALL ORDS
7,837.40
-100.10
(-1.26%)
ASX 200
7,575.90
-107.10
(-1.39%)
OIL
83.66
+0.09
(+0.11%)
Amylyx Pharmaceuticals, Inc. (AMLX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.7600
-0.0200
(-1.12%)
At close: 04:00PM EDT
1.8400
+0.08
(+4.55%)
After hours:
07:56PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
345
380,786
22,230
0
0
Cost of revenue
25,441
25,441
2,993
0
-
Gross profit
355,345
355,345
19,237
0
-
Operating expenses
Research development
84,031
128,187
93,450
44,040
24,594
Selling general and administrative
101,205
188,356
127,128
38,933
15,061
Total operating expenses
185,236
316,543
220,578
82,688
39,005
Operating income or loss
-185,063
38,802
-201,341
-82,688
-39,005
Interest expense
-
-
-
0
2,288
Total other income/expenses net
79
-660
-551
-5,279
-1,001
Income before tax
-183,820
54,297
-197,601
-87,931
-42,280
Income tax expense
5,026
5,026
774
0
-
Income from continuing operations
-184,015
49,271
-198,375
-87,931
-42,280
Net income
-184,015
49,271
-198,375
-87,931
-42,280
Net income available to common shareholders
-184,015
49,271
-198,375
-87,931
-42,280
Basic EPS
0.04
0.73
-3.39
-1.59
-0.92
Diluted EPS
0.01
0.70
-3.39
-1.59
-0.92
Basic average shares
66,716
67,234
58,496
55,216
45,951
Diluted average shares
68,981
69,991
58,496
55,216
45,951
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.